The surge in cannabis use among Americans over 60 represents a quiet revolution in how older adults approach chronic health challenges. While prescription medications often come with concerning side effects or diminishing returns, many seniors are exploring cannabis edibles as gentler alternatives for persistent pain, sleep disruption, and anxiety.
This Colorado-based qualitative study examined motivations and preferences among 169 adults aged 60 and older who were considering edible cannabis for therapeutic purposes. Participants expressed particular interest in CBD-dominant formulations for daytime pain management, THC-dominant products for sleep induction, and balanced THC-CBD combinations for addressing multiple symptoms simultaneously. The research captured detailed perspectives on how different cannabinoid profiles align with specific health goals and daily routines.
The findings illuminate a significant knowledge gap in geriatric medicine. While cannabis legalization has expanded rapidly, clinical guidance for older adults remains limited, leaving many to navigate product selection through trial and error. This demographic faces unique considerations including medication interactions, age-related metabolism changes, and heightened sensitivity to psychoactive effects. The study's focus on edibles is particularly relevant since this consumption method offers more predictable dosing and longer-lasting effects compared to smoking or vaping. However, the research limitations are substantial: it relies on self-reported perceptions rather than clinical outcomes, lacks long-term follow-up, and reflects experiences in a single legalized state. While encouraging for patient autonomy, these findings underscore the urgent need for controlled clinical trials examining cannabis efficacy and safety specifically in older populations.